OSR Health, Inc.

Name: OSR Health, Inc. standardized financial statements, quarterly
Creator: Listed

OSRHOTCCIK 1840425HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$315.7k, Q2 FY2026

Operating income−$3.0m, Q2 FY2026

Net income−$1.0m, Q2 FY2026

OSR Health, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	not reported	not reported	0.9	0.9	0.8	0.9	0.8	1.1	0.6	0.4	0.5	0.3
Cost of revenue	$m	not reported	not reported	0.7	0.6	0.6	0.8	0.6	1.1	0.4	0.3	0.3	0.2
Gross profit	$m	not reported	not reported	0.2	0.2	0.2	0.2	0.2	0.0	0.3	0.1	0.2	0.1
Research and development	$m	not reported	not reported	0.0	0.0	0.1	0.0	0.1	0.1	(0.0)	0.2	0.1	0.1
Selling, general and administrative	$m	0.4	0.9	3.5	3.4	3.7	1.8	3.1	5.3	4.1	6.5	3.8	3.1
Operating income	$m	not reported	not reported	(3.3)	(3.2)	(3.6)	(1.6)	(2.9)	(5.2)	(3.8)	(6.4)	(3.7)	(3.0)
Interest expense	$m	not reported	not reported	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0
Income tax	$m	0.1	0.2	0.0	(1.0)	(0.1)	(0.5)	not reported	not reported	(1.3)	(0.5)	(0.5)	(0.4)
Net income	$m	0.1	(0.1)	(0.1)	(0.1)	(0.2)	(2.0)	(11.4)	(5.2)	(3.2)	(7.2)	(3.5)	(1.0)
Diluted EPS	$ per share	0.01	not reported	(0.01)	(0.02)	(0.06)	not reported	(1.04)	not reported	not reported	not reported	(0.08)	not reported
Basic EPS	$ per share	0.01	not reported	(0.60)	(0.41)	(1.56)	not reported	(1.04)	0.02	(0.10)	not reported	(0.09)	(0.02)

Balance sheet

Cash and equivalents$1.5m, Q2 FY2026

Long-term debt$271.3k, Q2 FY2026

Shareholders' equity$124.9m, Q2 FY2026

OSR Health, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	0.1	0.0	0.0	0.1	0.0	0.3	1.6	1.6	2.2	1.7	1.6	1.5
Current assets	$m	0.1	0.0	0.1	0.2	0.0	2.3	3.5	2.9	3.2	2.8	2.9	2.9
Total assets	$m	72.1	36.6	37.3	20.6	20.9	175	175	185	177	171	172	167
Current liabilities	$m	1.1	2.0	2.7	3.4	3.9	3.5	13.9	15.9	15.0	17.2	17.9	15.7
Total liabilities	$m	3.2	4.1	4.8	5.5	6.0	32.0	42.3	46.3	43.1	44.2	44.8	41.7
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	0.5	0.3	not reported	0.0	not reported	0.3	0.3
Current portion of debt	$m	1.0	2.0	2.7	3.3	3.9	not reported	0.2	0.6	not reported	not reported	0.2	0.3
Short-term borrowings	$m	not reported	not reported	not reported	not reported	not reported	1.8	1.6	1.8	1.9	2.3	2.2	2.1
Shareholders' equity	$m	(2.5)	(3.9)	(4.3)	(4.9)	(5.8)	(8.3)	132	139	134	127	127	125

Cash flow

Operating cash flow−$2.4m, Q2 FY2026

Share repurchases$19.2m, Q4 FY2024

OSR Health, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$m	(0.1)	(0.3)	(0.5)	(0.5)	(0.7)	(0.2)	(0.1)	(0.5)	(2.7)	(1.1)	(1.0)	(2.4)
Share repurchases	$m	0.0	36.0	not reported	not reported	0.0	19.2	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)34.27m, Q1 FY2026

OSR Health, Inc., shares, quarterly
Line item	Unit	period not labelled2022-06-30	period not labelled2022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q1 FY20262026-03-31
Diluted shares (weighted)	m shares	1.5	1.5	5.2	9.1	9.1	5.6	4.9	4.0	10.9	34.3

Shares outstanding: 35.12m at Aug 10, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.